Records containing: Leukemia, Myelogenous, Chronic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-07Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
-
CLINICAL_TRIALS study record update · 2022-12-08A Bioequivalence Study Between the Generic Dasatinib Tablet and Reference Product in Vivo
-
CLINICAL_TRIALS study record update · 2019-09-11Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Oral Nilotinib
-
CLINICAL_TRIALS study record update · 2019-04-16Clinical Evaluation of the Xpert BCR-ABL Ultra Assay on the GeneXpert Instrument Systems
-
CLINICAL_TRIALS study record update · 2019-01-08A Multicenter Phase II Trial of Inhibition of CD26 Peptidase Using Sitagliptin to Enhance Engraftment After Umbilical Cord Blood Transplantation for Adults With Hematological Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-06-06A Phase I/II Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2016-08-04A Phase II Trial of Inhibition of CD26 Peptidase Using Sitagliptin to Enhance Engraftment After Umbilical Cord Blood Transplantation for Adults With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2015-08-31A PHASE I TRIAL OF ALLOREACTIVE NK CELLS INFUSION FOLLOWING TRANSPLANTATION OF HAPLOTYPE MISMATCHED, KIR MISMATCHED HIGHLY PURIFIED CD34 CELLS IN PATIENTS WITH ADVANCED OR REFRACTORY MYELOID MALIGNANCIES
-
CLINICAL_TRIALS study record update · 2015-06-11Early Post-transplant Contrast-enhanced Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation